Investing

5 Companies That Destroyed Shareholders Last Week

Chris Lange

Published: May 1, 2016 10:55 am

Last Updated: March 13, 2020 3:04 pm

Analysts are expecting some more earnings disappointments going forward, and even some giants have fallen so far. As this earnings season goes on, we might be seeing more companies destroying shareholders. Although the markets have made their comeback from a weak first quarter, some stocks are still slowing that recovery and punishing their shareholders.

We have picked out some companies that punished shareholders last week. Among the active stocks, these all issued or had news that pushed shares down. 24/7 Wall St. has included their recent trading history, as well as the 52-week trading range and the consensus analyst price target.

Catalyst Pharmaceuticals

Just Tuesday morning alone, Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) saw its shares get halved, following a business update regarding its Lambert-Eaton myasthenic syndrome (LEMS) treatment. The company provided an update on the content of the planned resubmission of the New Drug Application (NDA) to the the U.S. Food and Drug Administration (FDA) for Firdapse (amifampridine phosphate), which currently has Breakthrough Therapy and Orphan Drug designations for LEMS.

Over the course of the week, the stock was down 44%. Shares of Catalyst ended Friday at $0.68. The consensus analyst price target is $6.81, and the 52-week trading range is $0.51 to $5.80.

24/7 Wall St.
Bill Ackman Makes Massive Canadian Pacific Railway Insider Sell, Plus Under Armour, Intel, Philip Morris and More